Stay updated on Targeted Therapy for Incurable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Targeted Therapy for Incurable Lung Cancer Clinical Trial page.

Latest updates to the Targeted Therapy for Incurable Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for a phase II trial of targeted therapies for incurable non-small cell lung cancer, including its study details and posted results.SummaryDifference67%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide notice announces an NIH terminology transition, stating that agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.SummaryDifference1%

- Check30 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the expected content, indicating the page is currently inaccessible. As a result, the study details are not visible on the page.SummaryDifference21%

Stay in the know with updates to Targeted Therapy for Incurable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Targeted Therapy for Incurable Lung Cancer Clinical Trial page.